Projects per year
Personal profile
Education
- 1991 PhD. State university of new york at buffaloVirology
- 1990 M.S. State university of new york at BuffaloMol Biology
- 1986 M.S. National Taiwan University Institute of Plant Biology
- 1981 B.S. National Taiwan University Plant Biology
Experience
- 2019- Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2018- Professor, Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2012- Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2011-Senior Scientist/Consultant, PRI, Albany
- 2011- Board member/consultant Signal Transduction, Inc. Albany
- 2003-2011 Senior Scientist, Ordway Research Institute
- 2002-2010 Research Scientist, VA Medical Center Research
- 1999-2002 Assist professor, Albany Medical College
- 1994-1998 Research Fellow, Albany Medical College
Research Interests
- Biochemical and molecular biological medicine
Awards
- 2016 Excellent publication award at Taipei Medical University
- 2017 Enterprise innovation competition for 4 Universities, 1st place award
- 2017 Enterprise innovation competition Taipei Medical University 1st place award
- 2017 Enterprise innovation competition Ministry of Education Outstanding
- 2018 Outstanding publication award at Taipei Medical University First prize
- 2019 Dr. Ta-Cheng Tung's Basic Cancer Research Award
Related Link
Fingerprint
Dive into the research topics where Hung-Yun Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of Theranostic Liposomal Drug Delivery Strategies for Pancreatic Cancer Treatment
Lin, H.-Y. (PI)
12/1/25 → 11/30/26
Project: A - Government Institution › b - National Science and Technology Council
-
Enhancing Pancreatic Cancer Treatment: Investigating Dl-N2 Nanoparticles Targeting Integrin Αvβ3 for Targeted Therapy and Combination Treatment Strategies
Lin, H.-Y. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
To Define the Attributes of a Novel Theranostic Nanoparticle Dl-N2 to Targeted Integrin Αvβ3 Network in Cholangiocarcinoma(3/3)
Lin, H.-Y. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
File -
Pathogenic Role of Integrin Αvβ3—Pd-L1—Β-Catenin Axis and Its Therapeutic Strategies in Colorectal Cancer
Lin, H.-Y. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
To Define the Attributes of a Novel Theranostic Nanoparticle Dl-N2 to Targeted Integrin Αvβ3 Network in Cholangiocarcinoma(2/3)
Lin, H.-Y. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Association of blood transfusion-related DEHP exposure with gut microbiota alterations in preterm infants
Yang, Y. N., Yang, Y. C. S. H., Yang, S. N., Chen, Y. Y., Lin, H. Y. & Suen, J. L., Jan 1 2026, In: Jornal de Pediatria. 102, 1, 101476.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Development and validation of a prognostic model incorporating the blood urea nitrogen-to-albumin ratio for predicting mortality in methicillin-resistant Staphylococcus aureus bloodstream infection
Wang, Y. H., Wong, Y. S., Li, R. T., Huang, C. C., Lin, H. Y., Tsai, Y. W., Lin, Y. J., Lai, T. Y., Hsu, C. C., Jung, C. J. & Tai, Y. H., Dec 2026, In: BMC Infectious Diseases. 26, 1, 1076.Research output: Contribution to journal › Article › peer-review
Open Access -
Integrative Multi-Omics and Single-Cell Analysis Reveal THOC3 and THOC7 as Oncogenic RNA Processing Regulators in Lung Adenocarcinoma
Kumar, S., Wu, C. C., Solomon, D. D., Yen, M. C., Yeh, I. J., Ko, C. C., Xuan, D. T. M., Chang, K. F., Lin, H. R., Lin, H. Y., Shih, C. L., Chen, J. B., Lee, W. Y., Wang, C. Y., Lee, Y. K. & Nguyen, N. U. N., 2026, In: International Journal of Medical Sciences. 23, 4, p. 1408-1430 23 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma
Li, Z. L., Kumar, S., Yang, S. N., Chang, T. C., Huang, L. Y., Ko, C. C., Yang, Y. N., Yao, C. J., Crawford, D. R., Gionfra, F., Solomon, D. D., Lee, Y. K., Xuan, D. T. M., Lin, H. R., Wang, C. Y., Aher, A., Abhista, N. B., Shih, Y. J., Lee, S. Y. & Huang, H. M. & 3 others, , Dec 2026, In: Journal of Translational Medicine. 24, 1, 321.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Single-cell transcriptomics reveal PRRC1 as a malignant cell enriched driver of DNA repair and therapy resistance in glioblastoma
Kumar, S., Tsai, M. C., Solomon, D. D., Ngadio, J. L., Xuan, D. T. M., Ko, C. C., Lin, H. Y., Yen, M. C., Yeh, I. J., Lee, Y. K., Lin, H. R., Chuang, J. Y., Wang, C. Y. & Nguyen, N. U. N., May 2026, In: DNA Repair. 161, 103934.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus)